# Vaccination of Patients With Stage IV Melanoma With Dendritic Cells

> **NCT00125749** · PHASE1,PHASE2 · COMPLETED · sponsor: **Baylor Research Institute** · enrollment: 30 (actual)

## Conditions studied

- Melanoma
- Neoplasm Metastasis

## Interventions

- **BIOLOGICAL:** Dendritic cell vaccination

## Key facts

- **NCT ID:** NCT00125749
- **Lead sponsor:** Baylor Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-07
- **Primary completion:** 2007-06
- **Final completion:** 2007-06
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2017-06-12

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00125749

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00125749, "Vaccination of Patients With Stage IV Melanoma With Dendritic Cells". Retrieved via AI Analytics 2026-07-27 from https://api.ai-analytics.org/clinical/NCT00125749. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*